Portrait of Moran,, Jerry

Moran,, Jerry

U.S. Senator KS Republican Party

Congressional stock trade history disclosed under the STOCK Act, parsed and scored by FilingIQ.

Disclosed trades
184
Buys / sells
47% / 53%
Last trade
Sep 23, 2025
Last filing
Oct 27, 2025

Latest disclosed trades

Latest 10 of 184
Ticker Type Traded
GOOG Sell Sep 23, 2025
BRK.A Buy Sep 23, 2025
BRK.B Buy Sep 23, 2025
Alphabet Cl C Sell Sep 23, 2025
GOOG Buy May 8, 2025
Alphabet Cl C Buy May 8, 2025
BRK.B Buy Dec 16, 2024
BRK.A Buy Dec 16, 2024
BRK.A Sell Jul 29, 2024
BRK.B Sell Jul 29, 2024

Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window, and to see the FilingIQ Score on every trade.

Moran,, Jerry stock trade activity

FilingIQ has indexed 184 congressional stock trade disclosures for Moran,, Jerry. The most recent disclosed transaction is dated Sep 23, 2025.

Across the full history, 87 purchases and 97 sales have been disclosed under the STOCK Act.

Top tickers traded by Moran,, Jerry

Frequently asked

How many stock trades has Moran,, Jerry disclosed?
FilingIQ tracks 184 Periodic Transaction Report disclosures for Moran,, Jerry, with the most recent dated Sep 23, 2025. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
Is Moran,, Jerry a net buyer or net seller?
Across the disclosed trade history, 87 (47%) were purchases and 97 (53%) were sales. Compensation and exchanges are filtered out of these counts.
Where does FilingIQ's data on Moran,, Jerry come from?
Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.

Methodology & sources

Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.